Stockreport
Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth [Yahoo! Finance]
Last hologic, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
Moreover, Hologic's Molecular Diagnostics business is likely to register strong growth driven by a combination of newer assays like BV and CV/TV. We anticipate HOLX's second-quarter fiscal 2024 performance, scheduled for release on May 2 after the closing bell, to reflect these aspects. Click here to know how the company's overall fiscal second-quarter performance is expected to be. GYN Surgical Hologic's GYN Surgical is expected to have registered vital contributions from MyoSure and the related fluid system. The company is likely to have benefited from the strong performance of its latest NovaSure iteration, the NovaSure V5, in the fiscal second quarter. Further, we are also upbeat about the company's laparoscopic portfolio, which continues to build momentum and is growing into a larger driver for the division. Through Acessa and Bolder acquisitions, the company integrated Acessa's procedure and Bolder's advanced vessel sealing portfolio into its product line. We believe
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | HOLX | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
HOLX alerts
HOLX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOLX alerts
High impacting Hologic, Inc. news events
Weekly update
A roundup of the hottest topics
HOLX
NEWS
NEWS
- Hologic (HOLX) Is Considered a Good Investment by Brokers: Is That True? [Yahoo! Finance][Yahoo! Finance]
- Hologic: Women's Health Play Looks Healthier Itself May 13, 2024 3:56 AM ET [Seeking Alpha][Seeking Alpha]
- Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus from $89.00 to $95.00. They now have a "buy" rating on the stock.[MarketBeat]
- $2.75+ Epigenetic Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2023 & 2024-2029F [Yahoo! Finance][Yahoo! Finance]
- A Dive into Hologic (HOLX) International Revenue Trends and Forecasts [Yahoo! Finance][Yahoo! Finance]
- More
HOLX
SEC Filings
SEC Filings
- 5/3/24 - Form 8-K/A
- 5/3/24 - Form 10-Q
- 5/2/24 - Form 8-K
- HOLX's page on the SEC website
- More